|
Products & Therapeutic Areas
The Octapharma Product Portfolio
The Octapharma product portfolio is focused on plasma derivatives products for treatment in coagulation disorders, immune disease, and intensive care and emergency medicine. Click on the links for an overview of each product line.
The information presented in this section of the website is intended for healthcare professionals. Prescribing information may vary from country-to-country. Unless otherwise stated, the information supplied on the Octapharma website reflects the approved international product specifications. Country specific information for each product can be obtained from your local Octapharma office. Patients should consult their medical provider for further information about the products with regards to the treatment of specific medical conditions.
International Business Units
In order to better handle product and market related projects of an international and corporate scope and to enhance the cooperation with national marketing organisations, International Business Units (IBU’s) were established in 2006.
The IBUs are managed by three International Business Managers (IBMs), each of whom is responsible for a particular product line. The IBMs reside in corporate headquarters in Lachen, Switzerland and work collaboratively with a geographically diverse team of senior marketeers who contribute to international initiatives and provide valuable local market experience to the group.
You are welcome to contact them directly with your questions on the product. Please note that the persons listed below are international contacts, for local contacts please refer to the list of Octapharma's subsidiaries.
International Corporate Services
- International Congresses
- Website
- Corporate Marketing Materials
International Corporate Services - Corinne Landolt
|
|
 |
|
|
